Walder Wyss advised Boostbar, a Switzerland- and UK-based company specialising in unattended retail technology, on its EUR 16 million Series B equity financing round. Direttissima Growth Partners led the round in question, with participation from Capmont
Tags :Walder Wyss
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Advoro and Walder Wyss advised Helvetica Property Investors in connection with the merger of Helvetica Swiss Opportunity Fund into Helvetica Swiss Commercial Fund. The context Pursuant to the consolidation, the HSO Fund was delisted from
Walder Wyss advised the Laveba cooperative group throughout renewing and simplifying its organisational structure. The context Headquartered in, the Laveba group is a cooperative trading and service company operating in the energy sector under the
Walder Wyss advised areal robotic specialist Voliro, in connection with the extension of its Series A round, bringing the total raised to USD 23 million. The context The extension round encompassed new participation from noa and
Walder Wyss advised the Jacobs Foundation, an organization supporting child development and evidence-based education, as well as professional investment firm Jacobs Holding, in their transition from an intertwined setup to two independent institutions. The context
Banking & Finance
Deal & transactions
Walder Wyss with Swiss Life on Swiss Credit Partners investment
Walder Wyss advised Swiss Life in connection with its role as main investor on a CHF 1.2 billion in capital transaction to Swiss Credit Partners. The context As effect of the investment, The FINMA-licensed asset manager
Walder Wyss advised the German multi-service group WISAG on the acquisition of all shares in the facility services company Stampfli. Headquartered in Subingen, selling part Stampfli employs more than 2,500 people. The Walder Wyss team Partner
Walder Wyss advised Sequotech and its subsidiaries on a multicurrency credit facilities agreement for Sequotech Group. In connection with the operation UBS Switzerland acted as mandated lead arranger, coordinator, agent, security agent and original
Walder Wyss advised Swiss laboratory and in-process solutions specialist Buchi Labortechnik on its acquisition of the NeoSpectra platform from Si-Ware Systems. The object of the transaction encompasses Si-Ware Systems’ handheld NIR analyzer and the NeoSpectra
